Drug Trial Radar · NCT07145346
Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures
Last checked: Nov 20, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
80
Planned (sponsor's estimate)
Start
Nov 13, 2025
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- University of California, IrvineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Rib fractures cause a significant amount of pain and are associated with an increased risk of lung infections, long hospitalization, and increased cost. Effective pain control is the cornerstone of management to improve lung function and minimize complications. Most often this is done with a multimodal pain routine consisting of: acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), topical lidocaine, muscle relaxants, and opioids. However, suzetrigine is a promising alternative to treat acute pain associated with rib fractures. We think the addition of suzetrigine to a multimodal pain regimen will improve pain and decrease opioid use.
Conditions
- Rib Fractures
Interventions
Suzetrigine (SUZ)Drug
The intervention arm will receive oral suzetrigine (100 mg loading dose followed by 50 mg every 12 hours).
PlaceboDrug
The control arm will receive placebo capsules matched to suzetrigine for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of PainTime frame: Through study completion of index hospitalization (up to 2 years)
- Use of morphine and morphine equivalentsTime frame: Through study completion of index hospitalization (up to 2 years)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, Irvine
Orange, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.